Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 465 entries
View as:

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00270270 Org: User:
Start: - End: 07/31/89 Due: 07/31/90

Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00078039 Org: User:
Start: 03/31/04 End: 01/31/05 Due: 01/31/06

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00530166 Org: User:
Start: 07/31/07 End: 07/31/08 Due: 07/31/09

A Study to Evaluate the Effects of Rifampin on Single-Dose Pharmacokinetics of Canagliflozin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01395927 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

A Pharmacokinetic and Drug Interaction Study of JNJ-26489112 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01147887 Org: User:
Start: 06/30/10 End: 08/31/10 Due: 08/31/11

Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00828958 Org: User:
Start: 02/28/06 End: 09/30/06 Due: 09/30/07

A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00622765 Org: User:
Start: 11/30/07 End: 06/30/08 Due: 06/30/09

A Study to Investigate the Absorption, Metabolism, and Excretion of Canagliflozin (JNJ-28431754) in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01791231 Org: User:
Start: 08/31/07 End: 10/31/07 Due: 10/31/08

CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00653952 Org: User:
Start: 05/31/97 End: 04/30/00 Due: 04/30/01

Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00270049 Org: User:
Start: 11/30/90 End: 01/31/94 Due: 01/31/95

Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT00594516 Org: User:
Start: 12/31/07 End: 05/31/08 Due: 05/31/09

A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00236704 Org: User:
Start: 03/31/94 End: 12/31/99 Due: 12/31/00

An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00487435 Org: User:
Start: 06/30/07 End: 06/30/09 Due: 06/30/10

Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT

Phase: N/A Priority: Normal
NCT ID: NCT00236678 Org: User:
Start: 07/31/04 End: 01/31/06 Due: 01/31/07

Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00101634 Org: User:
Start: 12/31/04 End: 03/31/06 Due: 03/31/07

Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00344422 Org: User:
Start: 10/31/00 End: 06/30/04 Due: 06/30/05

An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options

Phase: N/A Priority: Normal
NCT ID: NCT01281540 Org: User:
Start: 05/31/03 End: 11/30/03 Due: 11/30/04

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00050427 Org: User:
Start: 12/31/02 End: 12/31/06 Due: 12/31/07

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00270166 Org: User:
Start: 02/28/95 End: 05/31/98 Due: 05/31/99

Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00425321 Org: User:
Start: 12/31/06 End: 01/31/08 Due: 01/31/09

As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations

Phase: N/A Priority: Normal
NCT ID: NCT00796185 Org: User:
Start: 08/31/03 End: 01/31/04 Due: 01/31/05

An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot

Phase: N/A Priority: Normal
NCT ID: NCT01110330 Org: User:
Start: 07/31/07 End: 10/31/08 Due: 10/31/09

A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.

Phase: N/A Priority: Normal
NCT ID: NCT00236795 Org: User:
Start: 01/31/97 End: 03/31/99 Due: 03/31/00

A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00791232 Org: User:
Start: 03/31/03 End: 06/30/03 Due: 06/30/04

Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

Phase: N/A Priority: Normal
NCT ID: NCT00709189 Org: User:
Start: 05/31/05 End: 08/31/05 Due: 08/31/06